<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01505387</url>
  </required_header>
  <id_info>
    <org_study_id>INQ/024511</org_study_id>
    <nct_id>NCT01505387</nct_id>
  </id_info>
  <brief_title>Litramine in Weight Maintenance</brief_title>
  <official_title>Double-blind, Randomized, Placebo-controlled Clinical Investigation to Evaluate the Safety and Efficacy of Litramine in Maintaining Body Weight Loss in Overweight and Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InQpharm Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InQpharm Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of Litramine on weight loss has previously been studied during a 12-week
      intervention period with promising results. The present study looks into the effect of weight
      maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change in Body Weight From Baseline to End of 24 Weeks</measure>
    <time_frame>24 weeks</time_frame>
    <description>Change in body weight at the end of 24 weeks measured in kg using a calibrated scale. (positive values signify weight gain, while negative values signify weight reduction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Waist and Hip Circumference (cm)</measure>
    <time_frame>24 weeks</time_frame>
    <description>Changes from baseline to end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (kg/m^2)</measure>
    <time_frame>24 weeks</time_frame>
    <description>Changes from baseline to end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full Blood Count</measure>
    <time_frame>24 weeks</time_frame>
    <description>Erythrocytes, leukocytes, thrombocytes, haematocrit, haemoglobin, Mean corpuscular volume (MCV), Mean corpuscular haemaglobin (MCH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>24 weeks</time_frame>
    <description>Measured in mm Hg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Weight Maintenance</condition>
  <condition>Overweight</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Litramine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fibre complex of plant origin n tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Litramine</intervention_name>
    <description>Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
    <arm_group_label>Litramine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented weight loss, achieved over the last 3 to 6 months either from participation
             in weight loss clinical trials or weight loss regimens, of at least 3% at the point of
             screening

          -  BMI 25-35 before initial weight loss

          -  Documented compliance (according to the investigator's judgement) to previous weight
             loss clinical trials/ regimens

        Exclusion Criteria:

          -  Known sensitivity to the ingredients of the device (citric acid, acacia or Fabaceae
             family)

          -  BMI &lt; 18.5

          -  Presence of other factor(s) that, in the investigator's judgement, should preclude
             subject participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Barbara Grube</name>
      <address>
        <city>Berlin</city>
        <zip>10709</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2012</study_first_submitted>
  <study_first_submitted_qc>January 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2012</study_first_posted>
  <results_first_submitted>March 24, 2015</results_first_submitted>
  <results_first_submitted_qc>March 24, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 3, 2015</results_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Weight maintenance</keyword>
  <keyword>Overweight</keyword>
  <keyword>Obese</keyword>
  <keyword>Weight management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Trial conducted from January 2012 to September 2012 in two study sites in Germany</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)
Placebo: Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
        <group group_id="P2">
          <title>Litramine</title>
          <description>Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)
Litramine: Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23">1 subject not included in intention to treat population as violated inclusion criteria</participants>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)
Placebo: Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
        <group group_id="B2">
          <title>Litramine</title>
          <description>Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)
Litramine: Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.1" spread="11.2"/>
                    <measurement group_id="B2" value="44.7" spread="11.4"/>
                    <measurement group_id="B3" value="44.4" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body weight (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.3" spread="9.0"/>
                    <measurement group_id="B2" value="78.2" spread="11.4"/>
                    <measurement group_id="B3" value="78.7" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (kg/m^2)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.7" spread="2.4"/>
                    <measurement group_id="B2" value="27.3" spread="2.1"/>
                    <measurement group_id="B3" value="27.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Change in Body Weight From Baseline to End of 24 Weeks</title>
        <description>Change in body weight at the end of 24 weeks measured in kg using a calibrated scale. (positive values signify weight gain, while negative values signify weight reduction</description>
        <time_frame>24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)
Placebo: Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)</description>
          </group>
          <group group_id="O2">
            <title>Litramine</title>
            <description>Fibre complex of plant origin n tablet form 2 tablets 3 times daily (oral consumption, after meal)
Litramine: Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Body Weight From Baseline to End of 24 Weeks</title>
          <description>Change in body weight at the end of 24 weeks measured in kg using a calibrated scale. (positive values signify weight gain, while negative values signify weight reduction</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="1.48"/>
                    <measurement group_id="O2" value="-0.62" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Waist and Hip Circumference (cm)</title>
        <description>Changes from baseline to end of study</description>
        <time_frame>24 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (kg/m^2)</title>
        <description>Changes from baseline to end of study</description>
        <time_frame>24 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Full Blood Count</title>
        <description>Erythrocytes, leukocytes, thrombocytes, haematocrit, haemoglobin, Mean corpuscular volume (MCV), Mean corpuscular haemaglobin (MCH)</description>
        <time_frame>24 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure</title>
        <description>Measured in mm Hg</description>
        <time_frame>24 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)
Placebo: Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
        <group group_id="E2">
          <title>Litramine</title>
          <description>Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)
Litramine: Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Felix Alt</name_or_title>
      <organization>Analyze &amp; Realize</organization>
      <phone>+49 30 40008100</phone>
      <email>Falt@a-r.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

